Acadian Asset Management LLC Angion Biomedica Corp. Transaction History

Acadian Asset Management LLC

  • $32.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$0.48 - $1.02 $432 - $918
-900 Reduced 3.64%
23,804 $13,000
Q2 2022

Aug 09, 2022
BUY
$1.1 - $2.23 $12,134 - $24,599
11,031 Added 80.68%
24,704 $28,000
Q4 2021

Feb 10, 2022
BUY
$2.35 - $9.95 $32,131 - $136,046
13,673 New
13,673 $39,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email